462
Views
20
CrossRef citations to date
0
Altmetric
Review

Epidemiology and treatment of relative anemia in children with sickle cell disease in sub-Saharan Africa

, &
Pages 1031-1042 | Received 09 Jun 2016, Accepted 21 Sep 2016, Published online: 17 Oct 2016

References

  • Hoffbrand V, Moss PA. Essential haematology. John Wiley & Sons; 2011. Available from: http://www.wileyessential.com/haematology/
  • Diallo DA, Guindo A. Sickle cell disease in sub-Saharan Africa: stakes and strategies for control of the disease. Curr Opin Hematol. 2014;21(3):210–214.
  • Beaumont C. Disorders of iron homeostasis, erythrocytes, erythropoiesis: the handbook: European school of haematology. Available from: http://www.esh.org/esh-handbook-on-disorders-of-iron-metabolism-2009/
  • Brown AK, Sleeper LA, Miller ST, et al. Reference values and hematologic changes from birth to 5 years in patients with sickle cell disease. Cooperative study of sickle cell disease. Arch Pediatr Adolesc Med. 1994;148:796–804.
  • Brown B, Jacob N, Lagunju I, et al. Morbidity and mortality pattern in hospitalized children with sickle cell disorders at the University College Hospital, Ibadan, Nigeria. Niger J Paediatr. 2013;40:34–39.
  • Gill FM, Sleeper LA, Weiner SJ, et al. Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative study of sickle cell disease. Blood. 1995;86:776–783.
  • Juwah AI, Nlemadim EU, Kaine W. Types of anaemic crises in paediatric patients with sickle cell anaemia seen in Enugu, Nigeria. Arch Dis Child. 2004;89:572–576.
  • Aloni MN, Tshimanga BK, Ekulu PM, et al. Malaria, clinical features and acute crisis in children suffering from sickle cell disease in resource-limited settings: a retrospective description of 90 cases. Pathog Glob Health. 2013;107:198–201.
  • Gardner K, Hoppe C, Mijovic A, et al. How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease. Br J Haematol. 2015;170:745–756.
  • Martyres DJ, Vijenthira A, Barrowman N, et al. Nutrient insufficiencies/Deficiencies in children with sickle cell disease and its association with increased disease severity. Pediatr Blood Cancer. 2016;63(6):1060–1064.
  • Vichinsky E, Kleman K, Embury S, et al. The diagnosis of iron deficiency anemia in sickle cell disease. Blood. 1981;58:963–968.
  • Carmel R, Bellevue R, Kelman Z. Low cobalamin levels associated with sickle cell disease: contrasting origins and clinical meanings in two instructive patients. Am J Hematol. 2010;85:436–439.
  • Kennedy TS, Fung EB, Kawchak DA, et al. Red blood cell folate and serum vitamin B12 status in children with sickle cell disease. J Pediatr Hematol Oncol. 2001;23:165–169.
  • Osungbade KO, Oladunjoye AO. Anaemia in developing countries: Burden and prospects of prevention and control. 2012. Available from: http://www.intechopen.com/books/anemia/anaemia-in-developing-countries-burden-and-prospects-of-prevention-and-control
  • Tolentino K, Friedman JF. An update on anemia in less developed countries. Am J Trop Med Hyg. 2007;77:44–51.
  • Camaschella C. Iron deficiency: new insights into diagnosis and treatment. Hematology Am Soc Hematol Educ Program. 2015;2015:8–13.
  • Balarajan Y, Ramakrishnan U, Ozaltin E, et al. Anaemia in low-income and middle-income countries. Lancet. 2011;378:2123–2135.
  • Okeahialam TC, Obi GO. Iron deficiency in sickle cell anaemia in Nigerian children. Ann Trop Paediatr. 1982;2:89–92.
  • Tshilolo L, Zita MN, Ngiyulu R, et al. Iron status in 72 Congolese patients with sickle cell anemia. Medecine et sante tropicales. 2016;26:83–87.
  • Jeremiah ZA, Buseri FI, Uko EK. Iron deficiency anaemia and evaluation of the utility of iron deficiency indicators among healthy Nigerian children. Hematology. 2007;12:249–253.
  • Dixit R, Nettem S, Madan SS, et al. Folate supplementation in people with sickle cell disease. Cochrane Database Syst Rev. 2016;2:CD011130.
  • Al-Momen AK. Diminished vitamin B12 levels in patients with severe sickle cell disease. J Intern Med. 1995;237:551–555.
  • Galadanci N, Wudil BJ, Balogun TM, et al. Current sickle cell disease management practices in Nigeria. Int Health. 2014;6:23–28.
  • Carmel R. The laboratory diagnosis of megaloblastic anemias. West J Med. 1978;128:294–304.
  • Uusiku NP, Oelofse A, Duodu KG, et al. Nutritional value of leafy vegetables of sub-Saharan Africa and their potential contribution to human health: a review. J Food Composition Anal. 2010;23:499–509.
  • Kwenin W, Wolli M, Dzomeku B. Assessing the nutritional value of some African indigenous green leafy vegetables in Ghana. J Anim Plant Sci. 2011;10:1300–1305.
  • Magalhaes RJ, Clements AC. Mapping the risk of anaemia in preschool-age children: the contribution of malnutrition, malaria, and helminth infections in West Africa. PLoS Med. 2011;8:e1000438.
  • Crawley J, Chu C, Mtove G, et al. Malaria in children. Lancet. 2010;375:1468–1481.
  • Makani J, Ofori-Acquah SF, Nnodu O, et al. Sickle cell disease: new opportunities and challenges in Africa. Scientific World J. 2013;2013:193252.
  • Bamidele Abiodun I, Oluwadun A, Olugbenga Ayoola A, et al. Plasmodium falciparum merozoite surface protein-1 polymorphisms among asymptomatic sickle cell anemia patients in Nigeria. Acta Medica Iranica. 2016;54:44–53.
  • Onwubalili JK. Sickle cell disease and infection. J Infect. 1983;7:2–20.
  • Greenwood BM, Bojang K, Whitty CJ, et al. Malaria. Lancet. 2005;365:1487–1498.
  • Crawley J. Reducing the burden of anemia in infants and young children in malaria-endemic countries of Africa: from evidence to action. Am J Trop Med Hyg. 2004;71:25–34.
  • Awolola TS, Oduola AO, Obansa JB, et al. Anopheles gambiae s.s. breeding in polluted water bodies in urban Lagos, southwestern Nigeria. J Vector Borne Dis. 2007;44:241–244.
  • Oniyangi O, Omari AA. Malaria chemoprophylaxis in sickle cell disease. Cochrane Database Syst Rev. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003489.
  • Olds GR. Deworming the world. Trans Am Clin Climatol Assoc. 2013;124:265–274.
  • World Health Organization. Soil Transmitted Helminthes. Fact sheet 2016.
  • Sodipo JO, Padgett D, Warrie E, et al. Parasitic infections in sickle cell crisis: Nigerian experience. J Natl Med Assoc. 1997;89:285–288.
  • Ahmed SG, Uraka J. Impact of intestinal parasites on haematological parameters of sickle-cell anaemia patients in Nigeria. East Mediterr Health J. 2011;17:710–713.
  • Bethony J, Brooker S, Albonico M, et al. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet. 2006;367:1521–1532.
  • Hotez PJ, Brooker S, Bethony JM, et al. Hookworm infection. N Engl J Med. 2004;351:799–807.
  • Centers for Disease Control and Prevention. Parasites-Hookworm. 2013.
  • Steketee RW. Pregnancy, nutrition and parasitic diseases. J Nutr. 2003;133:1661S–7S.
  • Stephenson LS, Holland CV, Cooper ES. The public health significance of Trichuris trichiura. Parasitology. 2000;121 Suppl:S73–95.
  • Friedman JF, Kanzaria HK, McGarvey ST. Human schistosomiasis and anemia: the relationship and potential mechanisms. Trends Parasitol. 2005;21:386–392.
  • Prevention Cfdca. Parasites-Schistosomiasis. 2012.
  • Gurarie D, Wang X, Bustinduy AL, et al. Modeling the effect of chronic schistosomiasis on childhood development and the potential for catch-up growth with different drug treatment strategies promoted for control of endemic schistosomiasis. Am J Trop Med Hyg. 2011;84:773–781.
  • Prual A, Daouda H, Develoux M, et al. Consequences of Schistosoma haematobium infection on the iron status of schoolchildren in Niger. Am J Trop Med Hyg. 1992;47:291–297.
  • Iwalokun BA, Iwalokun SO, Hodonu SO. Seroprevalence of parvovirus B19 antibodies and evidence of viremia among Nigerian patients with sickle cell anemia. J Biomed Res. 2013;27:272–282.
  • Quek L, Sharpe C, Dutt N, et al. Acute human parvovirus B19 infection and nephrotic syndrome in patients with sickle cell disease. Br J Haematol. 2010;149:289–291.
  • Ubesie A, Emodi I, Ikefuna A, et al. Prevalence of human immunodeficiency virus transmission among transfused children with sickle cell anemia in Enugu Nigeria. Ann Med Health Sci Res. 2012;2:109–113.
  • Jayaraman S, Chalabi Z, Perel P, et al. The risk of transfusion-transmitted infections in sub-Saharan Africa. Transfusion. 2010;50:433–442.
  • Diarra AB, Guindo A, Kouriba B, et al. Sickle cell anemia and transfusion safety in Bamako, Mali. Seroprevalence of HIV, HBV and HCV infections and alloimmunization belonged to Rh and Kell systems in sickle cell anemia patients. Transfus Clin Biol. 2013;20:476–481.
  • Damen JG, Barnabas O, Damulak D, et al. Malaria parasitemia in apparently healthy blood donors in north-central Nigeria. Lab Med. 2015;46:42–46.
  • Owusu-Ofori AK, Parry C, Bates I. Transfusion-transmitted malaria in countries where malaria is endemic: a review of the literature from sub-Saharan Africa. Clin Infect Dis. 2010;51:1192–1198.
  • World Health Organization. Screening Donated Blood For Transfusion Transmissible Infections. 2010.
  • World Health Organization. International Program on chemical safety: Lead. 2010.
  • Wright RO. The role of iron therapy in childhood plumbism. Curr Opin Pediatr. 1999;11:255.
  • Ajumobi OO, Tsofo A, Yango M, et al. High concentration of blood lead levels among young children in Bagega community, Zamfara - Nigeria and the potential risk factor. Pan Afr Med J. 2014;18(Suppl 1):14.
  • Dooyema CA, Neri A, Lo YC, et al. Outbreak of fatal childhood lead poisoning related to artisanal gold mining in northwestern Nigeria, 2010. Environ Health Perspect. 2012;120:601–607.
  • Howarth D. Pica – a case report. Aust Fam Physician. 2013;42:299–300.
  • Meier ER, Wright EC, Miller JL. Reticulocytosis and anemia are associated with an increased risk of death and stroke in the newborn cohort of the cooperative study of sickle cell disease. Am J Hematol. 2014;89:904–906.
  • Cancio MI, Helton KJ, Schreiber JE, et al. Silent cerebral infarcts in very young children with sickle cell anaemia are associated with a higher risk of stroke. Br J Haematol. 2015;171:120–129.
  • Lagunju I, Brown BJ, Sodeinde O. Hydroxyurea lowers transcranial Doppler flow velocities in children with sickle cell anaemia in a Nigerian cohort. Pediatr Blood Cancer. 2015;62:1587–1591.
  • Adams RJ. Big strokes in small persons. Arch Neurol. 2007;64:1567–1574.
  • Rees DC, Dick MC, Height SE, et al. A simple index using age, hemoglobin, and aspartate transaminase predicts increased intracerebral blood velocity as measured by transcranial Doppler scanning in children with sickle cell anemia. Pediatrics. 2008;121:e1628–32.
  • Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91:288–294.
  • DeBaun MR, Kirkham FJ. Central nervous system complications and management in sickle cell disease. Blood. 2016;127:829–838.
  • King AA, DeBaun MR, White DA. Need for cognitive rehabilitation for children with sickle cell disease and strokes. Expert Rev Neurother. 2008;8:291–296.
  • Steen RG, Xiong X, Mulhern RK, et al. Subtle brain abnormalities in children with sickle cell disease: relationship to blood hematocrit. Ann Neurol. 1999;45:279–286.
  • Wang M. Iron deficiency and other types of anemia in infants and children. Am Fam Physician. 2016;93:270–278.
  • Wolf RB, Saville BR, Roberts DO, et al. Factors associated with growth and blood pressure patterns in children with sickle cell anemia: silent cerebral infarct multi-center clinical trial cohort. Am J Hematol. 2015;90:2–7.
  • Hankins JS, Ware RE, Rogers ZR, et al. Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study. Blood. 2005;106:2269–2275.
  • World Health Organization. Nutrition Landscape Information system-Country Profile Indicators, Interpretation guide. 2010.
  • Esezobor CI, Akintan P, Akinsulie A, et al. Wasting and stunting are still prevalent in children with sickle cell anaemia in Lagos, Nigeria. Ital J Pediatr. 2016;42:45.
  • Cox SE, Makani J, Fulford AJ, et al. Nutritional status, hospitalization and mortality among patients with sickle cell anemia in Tanzania. Haematologica. 2011;96:948–953.
  • Wang WC, Ware RE, Miller ST, et al. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet. 2011;377:1663–1672.
  • Hankins JS, Penkert RR, Lavoie P, et al. Parvovirus B19 infection in children with sickle cell disease in the hydroxyurea era. Exp Biol Med (Maywood). 2016;241(7):749–754.
  • Ware RE. Optimizing hydroxyurea therapy for sickle cell anemia. Hematology Am Soc Hematol Educ Program. 2015;2015:436–443.
  • Ozdemir N. Iron deficiency anemia from diagnosis to treatment in children. Turk Pediatri Ars. 2015;50:11–19.
  • Makani J, Roberts DJ. Hematology in Africa. Hematol Oncol Clin North Am. 2016;30:457–475.
  • Quinn CT, Rogers ZR, McCavit TL, et al. Improved survival of children and adolescents with sickle cell disease. Blood. 2010;115:3447–3452.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.